Inhibition of mutant EGFR in lung adenocarcinoma cells has been shown to cause increased expression of FGFR3, and inhibition of FGFR3 was shown to block the formation of drug-tolerant cells [15]. This evidence concerns the gene EGFR and lung adenocarcinoma.